thromboembolism – Medxy AI

Ischaemic Stroke Risk in Atrial Flutter Versus Atrial Fibrillation: Insights from a Finnish Nationwide Registry Study

By MedXY 09/09/2026

This Finnish nationwide study demonstrates that patients with atrial flutter have a substantially lower risk of ischaemic stroke compared to those with atrial fibrillation, highlighting important differences in thromboembolic risk profiles between these arrhythmias.

Neurology news Radiology

Revolutionizing Stroke Diagnosis: Noninvasive Thrombus Imaging with [18F]GP1 PET/CT

By MedXY 09/04/2026

A novel noninvasive imaging technique using [18F]GP1 PET/CT enables direct identification of thrombi in acute ischemic stroke, improving etiologic classification and predicting recurrence risk, heralding mechanism-based stroke management.

Cardiology Neurology news

Balancing Risks: Safety Profiles of Antiseizure Medications in Epilepsy Patients on Direct Oral Anticoagulants

By MedXY 08/18/2026

This study reveals distinct thromboembolic, bleeding, and mortality risks based on antiseizure medication selection in epilepsy patients receiving direct oral anticoagulants, highlighting the critical role of ASM choice on patient safety and outcomes.

Cardiology news

Intracardiac Echocardiography Is Noninferior to Transesophageal Echocardiography for Thrombus Screening in Atrial Fibrillation Ablation — with Added Safety and Efficiency Gains

By MedXY 12/03/2025

A multicenter randomized trial (N=1,810) found intracardiac echocardiography (ICE) noninferior to transesophageal echocardiography (TEE) for preventing periprocedural thromboembolism in AF ablation, while reducing bleeding related to transseptal puncture, fluoroscopy time, preprocedural wait, and patient anxiety.

Clinical Updates news Oncology Specialties

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

By MedXY 09/08/2025

Venous and arterial thrombotic events in cancer patients are underreported in clinical trials, impairing risk assessment and prevention strategies. Uniform and comprehensive reporting is imperative to improve patient outcomes and guide therapeutic decisions.

Cardiology Diabetes & Endocrinology news Specialties

Association of Testosterone-Induced Neutrophil and Monocyte Elevation with Thromboembolic Risk: Insights from the TRAVERSE Trial

By MedXY 08/26/2025

The TRAVERSE trial reveals that testosterone replacement therapy elevates neutrophil and monocyte counts in hypogonadal men, correlating with increased venous thromboembolism and cardiovascular event risk, underscoring the need to monitor these leukocytes during therapy.